INT184750

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.08
First Reported 2005
Last Reported 2005
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 5
Disease Relevance 6.38
Pain Relevance 1.27

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

lyase activity (Car9) plasma membrane (Car9)
Car9 (Mus musculus)
Pain Link Frequency Relevance Heat
Chronic pancreatitis 42 99.00 Very High Very High Very High
imagery 12 97.64 Very High Very High Very High
Inflammation 12 95.04 Very High Very High Very High
withdrawal 2 90.16 High High
addiction 3 88.20 High High
palliative 6 11.84 Low Low
Bile 2 5.00 Very Low Very Low Very Low
Antiemetics 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pancreatic Cancer 94 100.00 Very High Very High Very High
Pancreatitis 45 99.00 Very High Very High Very High
Obstructive Jaundice 4 98.24 Very High Very High Very High
Cancer 68 98.04 Very High Very High Very High
INFLAMMATION 12 95.04 Very High Very High Very High
Toxicity 28 88.32 High High
Malignant Neoplastic Disease 45 86.80 High High
Appetite Loss 12 84.80 Quite High
Disease 44 83.40 Quite High
Recurrence 2 82.96 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In fourteen of seventeen patients (82%) assessed baseline CA19-9 levels were elevated (median 581, mean 98,849, range 115–1,244,000; normal < 32 U/mL).
Positive_regulation (elevated) of CA19-9
1) Confidence 0.08 Published 2005 Journal BMC Cancer Section Body Doc Link PMC1180427 Disease Relevance 0.78 Pain Relevance 0
Baseline CA19-9 levels were recorded in 17 patients and were elevated in 14 of them.
Positive_regulation (elevated) of CA19-9
2) Confidence 0.08 Published 2005 Journal BMC Cancer Section Body Doc Link PMC1180427 Disease Relevance 0.94 Pain Relevance 0.05
Serum carbohydrate antigen 19-9 (CA19-9) levels are elevated in 80% of pancreatic cancer patients, but can also be increased in 20% of patients with chronic pancreatitis [2].
Positive_regulation (increased) of CA19-9 associated with pancreatic cancer and chronic pancreatitis
3) Confidence 0.01 Published 2005 Journal BMC Gastroenterol Section Body Doc Link PMC1184069 Disease Relevance 1.77 Pain Relevance 0.52
Serum carbohydrate antigen 19-9 (CA19-9) levels are elevated in 80% of pancreatic cancer patients, but can also be increased in 20% of patients with chronic pancreatitis [2].
Positive_regulation (elevated) of CA19-9 associated with pancreatic cancer and chronic pancreatitis
4) Confidence 0.01 Published 2005 Journal BMC Gastroenterol Section Body Doc Link PMC1184069 Disease Relevance 1.66 Pain Relevance 0.51
PIF was detected in two patients with CA19-9 negative pancreatic cancer, but was not detectable in 16 pancreatic cancer patients (15 of them with elevated CA19-9).
Positive_regulation (elevated) of CA19-9 associated with pancreatic cancer
5) Confidence 0.01 Published 2005 Journal BMC Gastroenterol Section Body Doc Link PMC1184069 Disease Relevance 1.21 Pain Relevance 0.19

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox